Cancer chemotherapy: past is prologue.
D015120:6-Aminonicotinamide / Q000008:administration & dosage; D000818:Animals; D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001224:Aspartic Acid / Q000008:administration & dosage / Q000031:analogs & derivatives; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D008297:Male; D008325:Mammary Neoplasms, Experimental / Q000188:drug therapy*; D008727:Methotrexate / Q000008:administration & dosage; D008778:Methylthioinosine / Q000008:administration & dosage; D051379:Mice; D008807:Mice, Inbred BALB C; D008811:Mice, Inbred DBA; D010746:Phosphonoacetic Acid / Q000008:administration & dosage / Q000031:analogs & derivatives
D000964:Antimetabolites, Antineoplastic; D001224:Aspartic Acid; D015120:6-Aminonicotinamide; D008778:Methylthioinosine; C013195:sparfosic acid; D010746:Phosphonoacetic Acid; D005472:Fluorouracil; D008727:Methotrexate